Atlas Trials

Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study

Clinical trial NCT06054308 · WITHDRAWN

Trial details

NCT number
NCT06054308
Sponsor
Chinese University of Hong Kong
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2024-02-02
Primary completion
2026-02-02
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.